Cargando…
Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case
Thalidomide may be used as a treatment option for pyoderma gangrenosum (PG) and myelodysplastic syndrome (MDS). Herein, we aimed to report a patient who was treated well with thalidomide and whose diagnosis was PG with MDS. A 61-year-old man with painless ecchymotic lesions in his right upper extrem...
Autores principales: | Malkan, Umit Yavuz, Gunes, Gursel, Eliacik, Eylem, Haznedaroglu, Ibrahim Celalettin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803237/ https://www.ncbi.nlm.nih.gov/pubmed/27051318 http://dx.doi.org/10.2147/IMCRJ.S101000 |
Ejemplares similares
-
Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case
por: Malkan, Umit Yavuz, et al.
Publicado: (2015) -
A Case of Pyoderma Gangrenosum with Myelodysplastic Syndrome
por: Ha, Jae Won, et al.
Publicado: (2018) -
Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
por: Gunes, Gursel, et al.
Publicado: (2015) -
Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022) -
Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
por: Turk, Seyhan, et al.
Publicado: (2017)